Advancements in cancer research have led to more complex regimens and therapies.

Americans are paying too much for prescription drugs.

When it comes to cancer, sharing the good, bad and ugly on social media allows the community to heal together, a metastatic breast cancer survivor and comedian told CURE®.

Sen. Jacky Rosen (D-Nev.) wants the Department of Health and Human Services (HHS) to investigate why a low-cost generic cancer drug isn’t widely available to patients.

A key tool that businesses have counted on to keep a lid on employees’ drug spending—filling workers’ prescriptions by mail—is now driving up their costs.

Losing weight can protect you against cancers related to obesity, a new study finds.

Vaccines are making waves in the oncology world, with one experimental messenger RNA (mRNA) vaccine, mRNA-4157 (also known as V940), that when combined with the immuno­therapy Keytruda (pembrolizumab), was shown in the KEYNOTE- 942 trial to reduce the risk of melanoma recurrence or death by 44% compared with treatment with Keytruda alone.

On this edition of Your Call, we’re discussing what we can do to prevent cancer. While cancer deaths are falling in the US, new cases are on the rise, from 1.9 million in 2022, to over two million last year, according to the American Cancer Society.

Drug shortages and chemotherapy drug shortages in particular are a persistent problem for oncology providers and pharmacists today.

In a bid to prevent the patent system from being abused, the U.S. Patent and Trademark Office has proposed a new rule designed to stem the use of so-called patent thickets, which are wielded by pharmaceutical companies to delay the arrival of lower-cost generic medicines in the marketplace.